Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.58)
# 227
Out of 5,090 analysts
110
Total ratings
58%
Success rate
21.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHVS Pharvaris | Maintains: Buy | $32 → $39 | $26.42 | +47.62% | 1 | Dec 4, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $28 → $43 | $29.91 | +43.76% | 8 | Nov 18, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $22 → $19 | $22.26 | -14.65% | 7 | Nov 5, 2025 | |
| LXEO Lexeo Therapeutics | Initiates: Buy | $30 | $9.35 | +220.86% | 1 | Oct 15, 2025 | |
| QURE uniQure | Maintains: Buy | $28 → $95 | $21.33 | +345.38% | 7 | Sep 25, 2025 | |
| PEPG PepGen | Reiterates: Buy | $6 | $5.44 | +10.29% | 2 | Sep 24, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $90 → $92 | $81.68 | +12.63% | 6 | Sep 23, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $15 | $10.42 | +43.95% | 3 | Sep 22, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $19 → $34 | $41.71 | -18.48% | 3 | Sep 15, 2025 | |
| SLNO Soleno Therapeutics | Reiterates: Buy | $106 | $51.37 | +106.35% | 5 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $10 | $9.21 | +8.58% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $14 | $9.61 | +45.68% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $106 | $53.40 | +98.50% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $558 → $546 | $455.48 | +19.87% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $36.38 | +75.92% | 3 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $20.28 | +146.55% | 5 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $189 | $234.13 | -19.28% | 4 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $55 | $27.09 | +103.03% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $3.74 | +381.28% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $13.58 | +25.18% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $9.90 | +51.52% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | n/a | $56.88 | - | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $5.02 | +278.49% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.28 | +414.02% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $35.26 | -14.92% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $29 | $1.43 | +1,927.97% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $458.12 | - | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $5.05 | +454.46% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $20 | $7.49 | +167.02% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $123 | $31.59 | +289.36% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $54 | $26.69 | +102.32% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $1.14 | +5,163.16% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $27.73 | - | 3 | Jun 26, 2017 |
Pharvaris
Dec 4, 2025
Maintains: Buy
Price Target: $32 → $39
Current: $26.42
Upside: +47.62%
Centessa Pharmaceuticals
Nov 18, 2025
Maintains: Buy
Price Target: $28 → $43
Current: $29.91
Upside: +43.76%
Sarepta Therapeutics
Nov 5, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $22.26
Upside: -14.65%
Lexeo Therapeutics
Oct 15, 2025
Initiates: Buy
Price Target: $30
Current: $9.35
Upside: +220.86%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $28 → $95
Current: $21.33
Upside: +345.38%
PepGen
Sep 24, 2025
Reiterates: Buy
Price Target: $6
Current: $5.44
Upside: +10.29%
Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Buy
Price Target: $90 → $92
Current: $81.68
Upside: +12.63%
Rezolute
Sep 22, 2025
Reiterates: Buy
Price Target: $15
Current: $10.42
Upside: +43.95%
Maze Therapeutics
Sep 15, 2025
Maintains: Buy
Price Target: $19 → $34
Current: $41.71
Upside: -18.48%
Soleno Therapeutics
Aug 27, 2025
Reiterates: Buy
Price Target: $106
Current: $51.37
Upside: +106.35%
Aug 14, 2025
Maintains: Buy
Price Target: $40 → $10
Current: $9.21
Upside: +8.58%
Aug 13, 2025
Maintains: Buy
Price Target: $45 → $14
Current: $9.61
Upside: +45.68%
Aug 6, 2025
Maintains: Buy
Price Target: $101 → $106
Current: $53.40
Upside: +98.50%
Aug 6, 2025
Maintains: Buy
Price Target: $558 → $546
Current: $455.48
Upside: +19.87%
Jun 20, 2025
Reiterates: Buy
Price Target: $64
Current: $36.38
Upside: +75.92%
Jun 18, 2025
Reiterates: Buy
Price Target: $50
Current: $20.28
Upside: +146.55%
May 7, 2025
Maintains: Buy
Price Target: $195 → $189
Current: $234.13
Upside: -19.28%
May 7, 2025
Maintains: Buy
Price Target: $78 → $55
Current: $27.09
Upside: +103.03%
Dec 3, 2024
Reiterates: Buy
Price Target: $18
Current: $3.74
Upside: +381.28%
Dec 3, 2024
Reiterates: Buy
Price Target: $17
Current: $13.58
Upside: +25.18%
Nov 7, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $9.90
Upside: +51.52%
Jun 28, 2024
Assumes: Neutral
Price Target: n/a
Current: $56.88
Upside: -
Apr 30, 2024
Initiates: Buy
Price Target: $19
Current: $5.02
Upside: +278.49%
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $4.28
Upside: +414.02%
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $35.26
Upside: -14.92%
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $1.43
Upside: +1,927.97%
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $458.12
Upside: -
Dec 16, 2021
Initiates: Buy
Price Target: $28
Current: $5.05
Upside: +454.46%
Dec 15, 2020
Assumes: Buy
Price Target: $20
Current: $7.49
Upside: +167.02%
Aug 24, 2020
Downgrades: Neutral
Price Target: $270 → $123
Current: $31.59
Upside: +289.36%
Jul 9, 2020
Maintains: Buy
Price Target: $60 → $54
Current: $26.69
Upside: +102.32%
Dec 3, 2019
Downgrades: Neutral
Price Target: $60
Current: $1.14
Upside: +5,163.16%
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $27.73
Upside: -